Adverse Reaction Profiles Related to Gastrointestinal Bleeding Events Associated with BCR-ABL Tyrosine Kinase Inhibitors

Adverse Reaction Profiles Related to Gastrointestinal Bleeding Events Associated with BCR-ABL Tyrosine Kinase Inhibitors

<i>Background and Objectives</i>: The aim of this study is to investigate the characteristics of gastrointestinal bleeding events associated with BCR-ABL tyrosine kinase inhibitor (TKI) treatment, using the reporting odds ratio (ROR) of the adverse event reports submitted to the Japanese...

Full description

Bibliographic Details
Main Authors: Kei Kawada, Tomoaki Ishida, Kohei Jobu, Shumpei Morisawa, Naohisa Tamura, Shouhei Sugimoto, Masafumi Okazaki, Saburo Yoshioka, Mitsuhiko Miyamura
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Medicina
Subjects:
gastrointestinal bleeding
BCR-ABL tyrosine kinase inhibitor
dasatinib
imatinib
Japanese Adverse Drug Event Report database
chronic myeloid leukemia
Online Access:https://www.mdpi.com/1648-9144/58/10/1495

Internet

https://www.mdpi.com/1648-9144/58/10/1495

Similar Items